Jul 14, 2022
Dr. Stephen Moran, PhD — Reimagining Nuclear Medicine — Advanced Accelerator Applications, Novartis
Posted by Ira S. Pastor in categories: biotech/medical, chemistry, economics, health, quantum physics
Reimagining Nuclear Medicine — Dr. Stephen Moran, Ph.D., Global Program Head, Neuroendocrine Tumors & Other Radiosensitive Cancers, Advanced Accelerator Applications, Novartis
Dr. Stephen Moran, Ph.D., is Global Program Head, Neuroendocrine Tumors & Other Radiosensitive Cancers, for Advanced Accelerator Applications (AAA — https://www.adacap.com/), a Novartis company and also a member of the Oncology Development Unit Leadership Team at Novartis.